Introduction
Solubility of drugs is an essential information in drug discovery and development investigations. 1 Solubilization of low-soluble drugs are required to improve their bioavailability and preparation of liquid dosage forms. 2 Cosolvency or solvent mixing is a commonly used solubilization method to prepare topical, oral and parenteral dosage forms of lowsoluble drugs. 3 Propylene glycol (PG) is an odorless, colourless, viscous liquid that contains two hydroxyl groups. PG or 1,2-propanediol is considered as a relatively safe cosolvent which is used in oral, intravenous and topical pharmaceutical formulations. 4 Complex formation of drugs with cyclodextrins (CDs) is another method for solubilization which are used alone or in combination with other solubilization agents such as surfactants or cosolvents. CDs mainly betacyclodextrin (-CD) are used in the solubilization and/or stabilization of drugs in parenteral solutions, tablet, ointment, suppository, eye drop and nasal spray formulations. Combination of the cosolvents and CDs are used to improve the aqueous solubility of drugs and was concluded that cosolvent size and polarity, destabilization of drug-ligand complex and the formation of a ternary drug-ligand-cosolvent complex affect the solubility of drugs. 5, 6 Solubilities of lamotrigine, diazepam and clonazepam in PG + water mixtures in the absence 7 and presence of -CD 8 were reported. In this study, solubility of sodium phenytoin (for chemical structure see Figure 1 ) in PG + water mixtures in the presence of 5 or 10 mM of -CD at 25 ºC are determined and mathematically represented using a common cosolvency model. 
Methods and Materials

Materials
Sodium phenytoin (with mass fraction purity (m/m) of 0.993) was purchased from Alhavi pharmaceutical
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Experimental methods
The binary solvent mixtures of PG + water were prepared by mass with the uncertainty of 0.01 g. To prepare the solvent mixtures +5 or 10 mM -CD, aqueous and PG solutions of + 5 or 10 mM -CD were prepared, then appropriate masses of the solutions were mixed up. Different methods were presented for determining the solubility of drugs. 9 The solubility of sodium phenytoin was determined using saturating shake-flask method. Briefly, the excess drug was added to the prepared solutions and then they were placed on a shaker (Behdad, Tehran, Iran) in an incubator equipped with a temperature-controlling system (uncertainty of 0.2 ºC, Kimia Idea Pardaz Azarbayjan (KIPA) Co., Tabriz, Iran). After equilibrium (24 hrs), the saturated solutions were centrifuged in 10000 rpm for 10 min (MSEMicro Center MSB010.CX2.5, SANYO, Muriguchi City, Japan) and diluted by water + ethanol (96 % or 0.935 in mass fraction) 50:50 mixture. The absorbance was recorded at 258 nm using a UV-Vis spectrophotometer (Biotech-Ultraspec 2000, England). Concentrations of the diluted solutions were determined from the calibration curves. Each reported solubility value is an average of at three independent measurements. The mean relative standard deviation (RSD) of three repetitive experiments was 1.8 %.
Computational methods
In addition to the experimental determination of solubility, mathematical models are used to estimate drugs solubility as an alternative method. The JouybanAcree model is used to calculate the solubility of drugs in solvent mixtures at various temperatures 3 and presented as: is the minimum solubility, i.e. aqueous solubility of sodium phenytoin in the absence of -CD in this study. The experimental solubility data of sodium phenytoin in PG + water mixtures in the absence and presence of 5 or 10 mM -CD was fitted to Eq. 1. The fitted data of each drug in the studied systems were used to compute the accuracy of fitness using mean relative deviation (MRD) by:
Eq. (3) in which N is the number of data points in each set.
Results and Discussion
The measured solubilities of sodium phenytoin in PG + water in the absence and presence of 5 and 10 mM -CD solutions at 25 ºC are listed in Table 1 . Each experimental data point is the average of at least three repeated measurements with the measured molar solubilities being reproducible to within relative standard deviations (RSD) ranged from 0.4 to 6.1 %. An intrinsic (solubility of non-ionized form of the solute) aqueous solubility of 7.53  10 -5 M 11 and apparent or total (sum of ionized and non-ionized forms of the solute) aqueous solubility of 8.04  10 -5 M 12 was reported for phenytoin and its sodium salt form increased the solubility to 0.27 M. 13 The generated solubility of sodium phenytoin in this work (0.2520 M) is in a good agreement with the reported value. Figure 2 shows the solubility profile of sodium phenytoin in PG + water, PG + water + 5 mM -CD and PG + water + 10 mM -CD mixtures. Aqueous solubility of sodium phenytoin obtained in this work is 0.2520 M and is decreased after addition of 5 mM -CD (0.2285 M) or 10 mM -CD (0.1881 M). This could be due to lower solubility of the formed complex in comparison with the solubility of sodium phenytoin. Figure 3 illustrates the solubility ratio of sodium phenytoin (from this work) to phenytoin (data taken from the literature 12 ) in various mass fractions of PG at 25 C. As expected, the solubility of the ionized drug and consequently total solubility is decreased with decreasing the polarity of the solvent system (usually represented by the dielectric constant of the solvent mixture). These sort of data could be used in recrystalization studies where addition of an anti-solvent facilitates the crystallization process. Sciences, 2015, 21(Suppl 1), 152-156 Mabhoot & Jouyban. (4) however, we recommend the model as it appears in Eq. 1. Using this version, it is possible to train the model at 25 C and then predict the solubility in PG + water mixtures at other temperatures of interest employing the solubility data in the mono-solvents. This has been shown in earlier works [14] [15] [16] and such a capability could be extended for cosolubilization/desolubilization using cosolvents and complexing agents too. Table 3 reports the calculated  values for aqueous mixtures of PG, PG + 5 mM -CD and PG + 10 mM -CD. Addition of -CD was slightly decreased the solubilization power of PG from 0.42 to 0.26. It should be noted that  values are in logarithmic scale and one unit decrease in  means solubility change by a factor of 10.
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In conclusion, the generated data in this work extends the available solubility database of pharmaceuticals 17 and could be used in the pharmaceutical industries. Decreased solubility by addition of a complexing agent could provide diverse solubility data for proposing global cosolvency models. There are good agreements between generated data in this work and the previously reported data in the literature. The Jouyban-Acree model fits very well to the data and could be used to predict the solubility data at other solvent compositions. Table 3 . Numerical values of the solubilization powers PG , PG + 5 mM -CD and PG + 10 mM -CD02.
Solvent system
 PG + water 0.42 PG + water + 5 mM -CD 0.36 PG + water + 10 mM -CD 0.26
